This can degrade the peptide, altering its structure and function
This real-world, US population-based study aims to estimate the use of systemic corticosteroids among patients with AD and, among those using systemic corticosteroids, to assess and characterize exposure duration, treatment patterns, and the patients who are prescribed these medications
Mechanistic summaries on this page are provided for laboratory reference and should be interpreted within controlled experimental settings only. In diet-induced obese (DIO) mice, treatment with 5-Amino-1MQ at 20 mg/kg/day for 11 days via subcutaneous injection reduced body weight by approximately 5.1%, epididymal fat pad mass by 35%, adipocyte size by more than 30%, and plasma cholesterol by 30%, with no changes in food intake or observable adverse effects (Neelakantan et al., 2017)
Should be used under medical supervision due to potential side effects and interactions with other medications